期刊文献+

2型糖尿病患者血清血管生成因子浓度的变化 被引量:2

Changes in serum concentrations of angiogenic factors in patients with type 2 diabetes mellitus
原文传递
导出
摘要 选取42例2型糖尿病患者(DM组)、23例糖尿病合并不稳定型心绞痛患者(DM+UAP组)和36名正常健康者(对照组)。收集血清,然后使用蛋白芯片检测血清中血管内皮生长因子(VEGF)、血管形成蛋白(Ang)-1、Ang-2、血管生成素、血管抑制素、碱性成纤维细胞生长因子和血小板源性生长因子BB浓度。结果显示,DM组与对照组比较,所有7个因子的血清浓度差异均无统计学意义,而DM+UAP组Ang-2和VEGF水平较对照组显著增高[(3532.10±1813.72对2444.50±1152.21)pg/ml,(286.90±217.01对171.92±106.63)pg/ml,均P〈0.01]。7个血管生成因子浓度与HbA1、空腹血糖、餐后2h血糖、甘油三酯、高密度脂蛋白胆同醇和低密度脂蛋白胆同醇均无显著相关。 Forty-two patients with type 2 diabetes ( DM group), 23 type 2 diabetic patients with unstable angina pectoris ( DM + UAP group ), and 36 healthy subjects ( control group ) were enrolled in this study. Serum samples were collected for determining serum concentrations of vascular endothelial growth factor ( VEGF ) , Angiopoietin (Ang)-1, Ang-2, angiogenin, angiostatin, basic fibroblast growth factor, and platelet-derived growth factor-BB using protein array technology. The results showed that there were no significant differences in serum concentrations of all 7 angiogenic factors between control group and DM group. Whereas, serum concentrations of VEGF and Ang-2 were significantly increased in DM+UAP group compared with control group [ (3 532.10 ± 1 813.72 vs 2 444.50 ± 1 152.21 ) pg/ml, ( 286.90 ± 217.01 vs 171.92 ± 106.63 ) pg/ml, both P〈0.01 ]. Pearson's con'elation analysis revealed that serum concentrations of all 7 angiogenic factors were not related to HbA1c, fasting and 2 h postprandial plasma glucose, triglycerides, high density lipoprotein cholesterol, as well as low density lipoprotein cholesterol.
出处 《中华内分泌代谢杂志》 CAS CSCD 北大核心 2013年第9期765-767,共3页 Chinese Journal of Endocrinology and Metabolism
基金 国家自然科学基金资助项目(81160021) 广西自然科学基金资助项目(GXNSFA018223)
关键词 血管生成因子 糖尿病 2型 不稳定型心绞痛 蛋白芯片 Angiogenic factors Diabetes mellitus, type 2 Unstable angina pectoris Protein array
  • 相关文献

参考文献22

  • 1Han B, Baliqa R, Huang H, et al. Decreased cardiac expression of vascular endothelial growth factor and redox imbalance in murine diabetic cardiomyopathy. Am J Physiol Heart Circ Physiol, 2009,297 : H829-H835.
  • 2Mouquet F, Cuilleret F, Susen S, et al. Metabolic syndrome and collateral vessel formation in patients with documented occluded coronary arteries: association with hyperglycaenfia, insulin-resistance, adiponectin and plasminogen activator inhibitor-l. Eur Heart J, 2009, 30:840-849.
  • 3Witzenbichler B, Maisonpierre PC, Jones P, et al. Chemotactic properties of angiopoietin-1 and -2, ligands for the endothelial-specific receptor tyrosine kinase Tie2. J Biol Chem, 1998,273:18514-18521.
  • 4Peters KG. Vascular endothelial growth factor and the angiopoietins: working together to build a better blood vessel. Circ Res, 1998,83:342- 343.
  • 5Yamakawa M, Liu LX, Date T, et al. Hypoxia-inducible factor-1 mediates activation of cultured vascular endothelial cells by inducing multiple angiogenic factors. Circ Res, 2003,93:664573.
  • 6Boodhwani M, Sodha NR, Mieno S, et al. Functional, cellular, and molecular characterization of the angiogenic response to chronic myocardial ischemia in diabetes. Circulation, 2007,116 : 131-137.
  • 7Lu J, Yao YY, Dai QM, et al. Erythropoietin attenuates cardiac dysfunction by increasing myocardial angiogenesis and inhibiting interstitial fibrosis in diabetic rats. Cardiovasc Diabetol, 2012, 11: 105.
  • 8Mima A, Qi W, Hiraoka-Yamomoto J, et al. Retinal not systemic oxidative and inflammatory stress correlated with VEGF expression in rodent models of insulin resistance and diabetes. Invest Ophthalmol Vis Sci, 2012,53:8424-8432.
  • 9Mima A, Kitada M, Geraldes P, et al. Glomerular VEGF resistanceinduced by PKC/SHP-I activation and contribution to diabetic nephropathy. FASEB J, 2012,26:2963-2974.
  • 10Khazaei M, Fallahzadeh AR, Sharifi MR, et al. Effects of diabetes on myocardial capillary density and serum angiogenesis biomarkers in male rats. Clinics ( Sao Paulo), 2011,66 : 1419-1424.

同被引文献11

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部